# ESTRADIOL AND NORETHINDRONE ACETATE
> **ANDA207261** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2017-02-10
## Drug
- **FDA Application Number:** ANDA207261
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESTRADIOL AND NORETHINDRONE ACETATE
- **Generic name:** ESTRADIOL AND NORETHINDRONE ACETATE
- **Active ingredients:** ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed LLC
- **First approval:** 2017-02-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207261)
---
*MORVS · CC0 1.0*